155 - Applications of Flow Chemistry in Modern Drug Development (S11E5)

You know, it's kind of amazing how quickly some
new drugs seem to appear these days. Really is.
But what most of us probably don't think about
is how they're actually made. And apparently
that whole process is changing pretty significantly.
Yeah, that's right. There's this technology flow
chemistry that's really starting to make waves
in the pharmaceutical world. Exactly. You sent
over some fascinating stuff on this, and it really
got us thinking about flow chemistry and how
it could, well, maybe even revolutionize getting
medicines from from the lab bench to the pharmacy
shelf. So today we want to give everyone the
inside scoop on this approach. Explain why it's
important for the safety and availability of
drugs we might all rely on down the line. Absolutely.
So the plan for this deep dive is first to unpack
what flow chemistry actually is, especially for
making pharmaceuticals. Right. Then we'll dig
into the big advantages. particularly around
safety and scaling up the production of those
crucial active ingredients, the APIs. APIs, the
actual stuff in the medicine that does the work.
Exactly, the active pharmaceutical ingredients.
And finally, we'll look at some real concrete
examples of where it's being used right now.
OK, sounds good. So let's start right there.
What is flow chemistry? Lay it out for us. OK,
so. Fundamentally, flow chemistry means doing
chemical reactions inside a continuous stream,
usually within a tube or some kind of channel,
called a reactor. A continuous stream? Yeah,
think of it less like the old way, you know,
mixing everything in a big flask or tank, which
we call batch chemistry. Right, like baking a
cake one batch at a time. Sort of, yeah. Flow
chemistry is much more like a factory assembly
line. Your starting materials go in one end,
they react as they flow through the system, and
the finished product continuously comes out the
other end. OK, so it's always running, always
producing, not starting and stopping for each
batch, like a continuous production line. That's
a really good analogy. And instead of having
a huge volume of chemicals reacting all at once.
Which sounds potentially risky. It can be. With
flow, you're dealing with much, much smaller
volumes moving through the reactor at any given
moment. but it's moving constantly. And this
continuous nature, this way of working, it offers
some really powerful advantages, especially when
you're making complex molecules like APIs. Alright,
let's get into those advantages then. This is
where it starts to sound really transformative.
You mentioned safety first. How does doing reactions
in this flowing stream make things inherently
safer? Well, probably the biggest safety benefit
comes directly from that small volume I mentioned.
Because you're only reacting tiny amounts at
any single point in time, the potential hazard,
if something goes wrong, is drastically reduced.
Think about reactions that generate a lot of
heat. Exothermic reactions. Exactly, exothermic
reactions. Or situations where you might form
unstable intermediate chemicals. Yeah. Handling
those in small, continuously moving quantities
is just inherently less dangerous than having
a huge vat of the stuff. Yeah, that makes total
sense. Less material means less potential energy
release, less risk of a runaway reaction. Precisely.
And there's another angle, too. Flow systems
allow for incredibly precise control over the
reaction conditions. Like temperature and pressure.
Temperature, pressure, mixing. All of it. Because
the reaction zone is small and well -defined,
you can heat or cool it very efficiently, mix
things perfectly. These parameters can be monitored
and adjusted in real time. often automatically.
Ah, so automation plays a big role here. It can,
yes. And that level of tight control really minimizes
the chances of unwanted side reactions or things
getting out of hand. It leads to a much more
stable, predictable process. Better control equals
better safety. Got it. OK, what about the next
big hurdle in drug making, scalability? Going
from making grams in the lab to potentially tons
for the market, how does flow chemistry help
there? This is actually one of the most elegant
aspects, I think. It's a concept often called
numbering up or scaling out. Numbering up. Yeah.
So instead of building one absolutely gigantic,
maybe difficult to manage batch reactor. Which
I imagine gets exponentially harder to control
as it gets bigger. It does. Mixing becomes uneven.
Temperature gradients form. It's a real challenge.
With flow chemistry, to increase production,
you don't necessarily build a bigger reactor.
You just run more identical small reactors in
parallel. Oh, I see. Like adding more assembly
lines instead of trying to make one massive one.
Exactly that. You have your optimized, efficient,
safe flow reactor unit. And if you need 10 times
the output, you just set up 10 of them running
side by side. That sounds incredibly more flexible
and, well, logical. It is. It avoids many of
the pitfalls of traditional scale up. And because
each of those parallel units operates under the
same precisely controlled conditions, you get
very consistent product quality batch after batch,
or rather, stream after stream. Scale -up becomes
much more predictable. Consistency is key in
pharmaceuticals, obviously. Absolutely critical.
And this inherent predictability and control
also lends itself really well to automation,
as you pointed out earlier. You can imagine integrated
systems where the flow reactors are connected
directly to purification units, all running continuously
and automatically. It streamlines the whole manufacturing
chain. OK, so the picture is smaller volumes,
much safer, easier to control, easier to scale
by duplication, and great for automation. It
really does sound like a paradigm shift. It has
that potential, definitely. Can you give us some
specific recent examples? Where is this actually
being put into practice for making drugs or their
essential components? Yeah, absolutely. There
are quite a few now. One interesting case involves
something called the Barbier reaction. Barbier
reaction rings a bell, but refresh my memory.
Sure. It's a type of reaction chemists use to
form carbon -carbon bonds, which is, you know,
fundamental for building the skeletons of most
drug molecules. Okay, making the basic structure.
Exactly. And researchers have successfully used
flow chemistry to perform a Barbier reaction
needed to make a key intermediate for the drug,
edivoxetine. Edivoxetine. That's used for ADHD,
right? That's the one. Attention deficit hyperactivity
disorder. by adapting this specific chemical
step to a continuous flow process. They found
they could get better yields, meaning more of
the desired product, and crucially, they improved
the safety profile compared to doing it in a
traditional batch setup. The small scale and
precise control were key. Better yield, better
safety. That's a clear win -win for making that
specific medicine component. Definitely. Okay,
what's another example? Another important area
is the preparation of isocyanates. Isocyanates
sounds familiar, but also... Potentially tricky.
They are. Isocyanates are very reactive chemical
building blocks used in synthesizing lots of
things, including some pharmaceuticals. But they
can be hazardous materials to work with. Right.
Reactive usually means you need to be careful.
Extremely careful. Traditional large batch production
of isocyanates or handling their precursors can
involve significant safety risks. So flow chemistry
offers an advantage here too. A big one, yes.
By generating and immediately using isocyanates
within a contained flow reactor. Ah, so you make
it and use it right away in the flow. Exactly.
You minimize the amount of this hazardous material
present at any one time. The precise temperature
control in flow systems is also vital for handling
these reactive species safely. It significantly
reduces the risks compared to bulk handling.
So it enables the safer use of these really useful
but potentially dangerous chemical tools. Precisely.
It makes the process safer for the operators
and can also lead to cleaner reactions and higher
purity products because you have better control.
That makes sense. So stepping back, how does
all this connect to the bigger picture of drug
development and getting treatments to patients?
Well, technologies like flow chemistry fit perfectly
with the overall goals in the pharmaceutical
industry. Everyone wants manufacturing to be
more efficient. greener, meaning less waste safer,
and ultimately more cost effective. Flow chemistry
kicks a lot of those boxes. If you can make APIs
more reliably, more safely, and potentially faster
or cheaper, that has downstream benefits. It
could lead to lower drug costs eventually, or
faster development timelines, getting new medicines
to patients sooner. So for our listeners, what's
the main takeaway here? When they hear about
a new drug, what should they remember about how
it might have been made using something like
flow chemistry? I think the key thing is to realize
that there's constant innovation happening behind
the scenes in the actual manufacturing science.
And things like flow chemistry represent a move
towards smarter, safer, and more efficient ways
to produce the medicines we rely on. It's about
improving the underlying processes to ensure
a reliable, high -quality supply of therapies.
It's easy to forget all the complex chemistry
and engineering that goes into that pill bottle.
Flow chemistry seems like a really important
part of that hidden process. It really is becoming
one. And it makes you think, doesn't it? Well,
if this continuous, controlled, often automated
approach works so well, what's the future? Could
we see maybe small, modular, fully automated
drug factories popping up? Like plug and play
drug manufacturing? Sort of. Imagine the implications.
Could that enable truly personalized medicine
production on demand or allow us to set up rapid
production facilities anywhere in the world during
a health crisis? Wow, yeah. That opens up a whole
range of possibilities from super customized
treatments to pandemic response. Exactly. It's
definitely something to keep an eye on how these
manufacturing technologies continue to evolve
and what that means for the future of medicine.